Other OTC Pharmaceuticals - Netherlands

Netherlands

Highlights

In the Netherlands, the revenue in the Other OTC Pharmaceuticals sector reached US$138.10m in 2024.
It is projected to experience an annual growth rate of 0.78% (CAGR 2024-2029).
When compared to other countries globally, the United States generates the highest revenue in this market, amounting to US$7.17bn in 2024.
In terms of per capita figures, the revenue per person in the Netherlands is US$7.81 in 2024.
The Netherlands has seen a rise in demand for natural and herbal OTC pharmaceuticals in recent years.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Other OTC Pharmaceuticals market in Netherlands is experiencing steady growth due to changing customer preferences, emerging trends, and local special circumstances.

Customer preferences: Customers in the Netherlands are increasingly seeking self-care options for minor health issues, which has led to a rise in demand for over-the-counter (OTC) pharmaceutical products. This preference for self-care is driven by factors such as convenience, cost-effectiveness, and the desire for quick relief from common ailments. Additionally, the growing health consciousness among consumers has led to an increased focus on preventive healthcare, further driving the demand for OTC pharmaceuticals.

Trends in the market: One of the key trends in the Other OTC Pharmaceuticals market in Netherlands is the increasing popularity of natural and herbal remedies. Consumers are becoming more conscious of the potential side effects of synthetic drugs and are opting for natural alternatives. This has led to a surge in demand for herbal supplements, homeopathic remedies, and natural skincare products. Manufacturers are capitalizing on this trend by introducing a wide range of natural and herbal OTC products to cater to the growing demand.Another trend observed in the market is the rising adoption of online channels for purchasing OTC pharmaceuticals. With the increasing penetration of internet and smartphones, consumers are increasingly turning to online platforms to purchase healthcare products. The convenience of online shopping, along with the availability of a wide range of products and competitive pricing, has made online channels a preferred choice for many consumers. This shift towards online retailing has prompted pharmacies and other retailers to establish their online presence and offer home delivery services.

Local special circumstances: The Netherlands has a well-developed healthcare system, which includes a strong emphasis on self-care and self-medication. The government actively promotes self-care as a means to reduce the burden on healthcare services and improve overall public health. This has created a favorable environment for the growth of the Other OTC Pharmaceuticals market in the country.Furthermore, the Netherlands has a high level of healthcare literacy among its population. People are well-informed about their health and are proactive in managing minor health issues on their own. This cultural attitude towards self-care has contributed to the growth of the OTC pharmaceuticals market in the country.

Underlying macroeconomic factors: The strong economy of the Netherlands, coupled with a high disposable income among its population, has contributed to the growth of the Other OTC Pharmaceuticals market. Consumers have the financial means to purchase OTC products and are willing to spend on their health and well-being. Additionally, the aging population in the country has increased the demand for OTC pharmaceuticals, as older individuals are more likely to experience common health issues that can be self-managed.In conclusion, the Other OTC Pharmaceuticals market in Netherlands is witnessing growth due to changing customer preferences, such as the preference for self-care and natural remedies, as well as the increasing adoption of online channels for purchasing healthcare products. The local special circumstances, including a focus on self-care and a high level of healthcare literacy, further contribute to the market growth. The strong economy and high disposable income in the country also play a significant role in driving the demand for OTC pharmaceuticals.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.